Isabella Sojo

Juan Pablo Elías

Gabriela Martínez
Luis Felipe Salazar
01 Description of
the company
○ It is a research-based, global pharmaceutical ○ It sells products to wholesalers,
company distributors, retailers, hospital clinics,
government agencies, pharmacies,
veterians, livestock producers, and
grocery.
○ Discovers, develop, manufactures, and markets
medicines for humans and animals.

○ Pfizer inc headquarters are in new york.

○ Pfizer diversifies global healthcare portfolio

in: human and animal biologic, small
Sector(s) Industry Full time
molecules medicines and vaccines, nutritional employees
products and healthcare products.
Healthcare Drug 88,300
Manufacturers
02
Antecedents &
Management
Performance
 ANTECEDENTS
1849 1936 1944 1951
Cousins Charles Pfizer and Doctor Richard Pasternack Using deep-tank fermentation, Pfizer operations are established
Charles Erhart founded develops a fermentation-free Pfizer is successful in its efforts to in Belgium, Brazil, Canada,
Charles Pfizer & Company method for producing ascorbic mass-produce penicillin and Cuba, England, Mexico,
in a red brick building in acid, vitamin C. Pfizer becomes the world's largest Panama, and Puerto Rico.
Brooklyn, NY becomes the world's leading producer of the "miracle drug."
producer of vitamin C.

2000 2010 2016

Pfizer announces a diversified R&D Watson Health and Pfizer announce a
Pfizer and Warner-Lambert merge to platform named Pfizer Worldwide collaboration to help accelerate Pfizer's
form the new Pfizer, creating the Research and Development, research in immuno-oncology, an
world's fastest-growing major supporting excellence in small and approach to cancer treatment that uses
pharmaceutical company. large molecules and vaccine the body's immune system to help fight
research and development. cancer.
 MANAGEMENT PERFORMANCE

ROI

DEC 2015 DEC 2016 DEC 2017 DEC 2018 DEC 2019 JUN 2020

7,31% 7,80% 21,92% 11,06% 16,61% 13,57%

STOCK PRICE

DEC 2015 DEC 2016 DEC 2017 DEC 2018 DEC 2019 MAR - JUN 2020

27,02 28,23 32,71 40,84 30,01 28,43 - 31,87

Source: https://www.macrotrends.net/stocks/charts/PFE/pfizer/stock-price-history
 Why did this happened?
- In November 2017 the company announced that Albert Bourla has been named Chief Operating Officer, this
could have drive the stock price up for that and next year because Bourla had a well known reputation in the
company. (Pfizer, 2017)

- In October 2018, the Board of directors announced Dr. Albert Bourla as the new CEO. (Pfizer, 2018)

- In 2019, Pfizer stock price went down because they announced a merger with Mylan, which investors believed
would reduce the company's free cash flow. (Pfizer, 2019)

- The price fell in march 2020 due to the supply disruptions for drugs from China, after June it started rising again
after the CEO John Young announced that they were looking for a vaccine. (FiercePharma, 2020)

- Regarding the ROI a spokesperson of Pfizer said "At Pfizer, there is no thought being given to 'ROI' in our
COVID-19 work. Instead our decisions are being driven by three priorities: the health and safety of our colleagues,
the continued supply of our medicines and vaccines, and finding medical solutions to this crisis," (FiercePharma,
2020)
03 Fundamental
Analysis
 Strength Weaknesse
s s
- For the last five years, Pfizer has belong to the top 5
companies of the healthcare sector worldwide, and has been the
SWOT Analysis - Pfizer is on the 12th position of the biggest consumer health
sector (Asia Pacific)and it is only in the top 5 companies of
2nd biggest company of the second largest market by region, the consumer health sector of one region. (Passport
North America. (Passport Euromonitor, 2020) Euromonitor, 2020)
- Advil has held the number one spot in global analgesics since - Pfizer relies heavily on the popularity of a couple of brands,
2010, resulting in USD1.1 billion in sales in 2017 and 4% of that are competing in very competent markets. For example,
total market share. Also, Pfizer has a growing portfolio on Advil does not play in any significant role in any market
biosimilars which is a market that has been growing for the last Internal outside North America. (Passport Euromonitor, 2017)
- In 2020 the company presented a current ratio below 1,
couple of years. (Passport Euromonitor, 2017)
- High profitability ratios like ROE and ROA. And a unlike the other years which was above 1 (Macrotrends,
debt/equity ratio below 1 (Macrotrends, 2020) 2020)

Opportunitie Threats
s External Internal
- In this sector, companies are constantly threatening with
- North America is the second region with the highest GDP and the doing mergers or acquiring portfolios. For example, when in
one with the lowest inflation ratio, which makes it a stable market 2016 Sanofi purchased Boehringer Ingelheim’s.
for business. (Passport Euromonitor, 2020) - Companies that don’t belong to this sector or industry are
- The current pandemic is an opportunity for the sector and industry trying to enter due to all the market opportunities, like Nestlé.
because countries will invest more on keeping their people safe. - Consumers fear dangerous side effects and certain markets
- Expansion opportunities to Asia Pacific and Latin America’s
markets.
External are on current decline, like the proton pump inhibitor one.
(Passport Euromonitor, 2017)
- The health care sector is turning into preventative and precise. - North America is the region with the biggest amount of
- OTC markets are expected to experience strong growth across pharmaceutical companies, which makes it a very competitive
global regions market.
(Passport Euromonitor, 2017) (Passport Euromonitor, 2020)
04 Peer Analysis
 PEER ANALYSIS

Johnson & Johnson Roche Holding AG Novartis AG

Sector(s): Healthcare Sector(s): Healthcare Sector(s): Healthcare

Industry: Drug Manufacturers Industry: Drug Manufacturers Industry: Drug Manufacturers

Full Time Employees: 132,200 Full Time Employees: 97,735 Full Time Employees: 110,000
 THANKS
CREDITS: This presentation template was created by Slidesgo, including icons by Flaticon,
and infographics & images by Freepik
 REFERENCES
10-K. (2015). Retrieved April 22, 2019, from Sec.gov website: https://www.sec.gov/Archives/edgar/data/78003/000007800316000077/pfe-12312015x10kshell.htm

Anderson, M. (2020, March 4). Top 10 pharma companies by revenue. Retrieved from www.beckershospitalreview.com website: https://www.beckershospitalreview.com/pharmacy/top-10-pharma-companies-by-revenue.html

Budwell, G. (2020, January 16). Why Pfizer Stock Fell 10.2% in 2019. Retrieved from The Motley Fool website: https://www.fool.com/investing/2020/01/16/why-pfizer-stock-fell-102-in-2019.aspx

GlobalData presents top 20 global innovative pharma companies by market capitalization in Q1 2019. (2019, October 9). Retrieved September 8, 2020, from GlobalData website: https://www.globaldata.com/globaldata-presents-top-20-global-innovative-pharma-companies-by-market-

capitalization-in-q1-2019/

GlobalData’s Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData. (2019, May 3). Retrieved May 3, 2019, from GlobalData website: https://www.globaldata.com/globaldatas-top-20-global-pharmaceutical-companies-by-market-cap-

year-ended-december-31-2018/

Johnson & Johnson (JNJ) Company Profile & Facts - Yahoo Finance. (n.d.). Retrieved from finance.yahoo.com website: https://finance.yahoo.com/quote/JNJ/profile?p=JNJ

Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination. (2019, November 12). Retrieved September 8, 2020, from investors.pfizer.com website: https://investors.pfizer.com/investor-news/press-release-details/2019/Mylan-and-Pfizer-

Announce-Viatris-as-the-New-Company-Name-in-the-Planned-Mylan-Upjohn-Combination/default.aspx

Novartis AG (NVS) Company Profile & Facts - Yahoo Finance. (n.d.). Retrieved September 8, 2020, from finance.yahoo.com website: https://finance.yahoo.com/quote/NVS/profile?p=N

PFE - Pfizer Inc Financial Results - CNNMoney.com. (n.d.). Retrieved September 8, 2020, from money.cnn.com website: https://money.cnn.com/quote/financials/financials.html?symb=PFE

Pfizer Announces CEO Succession. (2018, October 1). Retrieved from investors.pfizer.com website: https://investors.pfizer.com/investor-news/press-release-details/2018/Pfizer-Announces-CEO-Succession/default.aspx

Pfizer, Inc. (PFE) Company Profile & Facts - Yahoo Finance. (n.d.). Retrieved September 8, 2020, from finance.yahoo.com website: https://finance.yahoo.com/quote/PFE/profile?p=PFE

Pfizer Names Albert Bourla Chief Operating Officer. (2017, November 13). Retrieved September 8, 2020, from investors.pfizer.com website: https://investors.pfizer.com/investor-news/press-release-details/2017/Pfizer-Names-Albert-Bourla-Chief-Operating-Officer/default.aspx

Pfizer: One of the world’s premier biopharmaceutical companies. (2018). Retrieved from Pfizer.com website: https://www.pfizer.com/

Pfizer Products | Pfizer. (n.d.). Retrieved September 8, 2020, from www.pfizer.com website: https://www.pfizer.com/products-list

Reddy, M. (2019, November 19). Digital Transformation in Healthcare in 2019: 7 Key Trends - Digital Authority. Retrieved from Digital Authority website: https://www.digitalauthority.me/resources/state-of-digital-transformation-healthcare/

Renauer, C. (2018, November 15). Why Pfizer Is Up 19% in 2018 So Far. Retrieved September 8, 2020, from The Motley Fool website: https://www.fool.com/investing/2018/11/15/why-pfizer-is-up-19-in-2018-so-far.aspx

ROCHE HOLDINGS AG (RHHBY) Company Profile & Facts - Yahoo Finance. (n.d.). Retrieved September 8, 2020, from finance.yahoo.com website: https://finance.yahoo.com/quote/RHHBY/profile?p=RHHBY

Team, T. (2020, March 16). Will Pfizer Stock Outperform The Broader Market Post Coronavirus? Retrieved September 8, 2020, from Forbes website: https://www.forbes.com/sites/greatspeculations/2020/03/16/will-pfizer-stock-outperform-the-broader-market-post-

coronavirus/#e0c3d0f15ffd

The World Bank. (2020, June 8). The Global Economic Outlook During the COVID-19 Pandemic: A Changed World. Retrieved from World Bank website: https://www.worldbank.org/en/news/feature/2020/06/08/the-global-economic-outlook-during-the-covid-19-pandemic-a-changed-

world

Trends Transforming The Pharmaceutical Manufacturing Industry Outlook in 2020. (2020, July 29). Retrieved September 8, 2020, from Linchpin SEO website: https://linchpinseo.com/trends-in-the-pharmaceutical-manufacturing-industry/

Weintraub, A. (2020, June 11). BIO: What’s the ROI on a COVID-19 vaccine? We have no idea, says Pfizer. Retrieved from FiercePharma website: https://www.fiercepharma.com/pharma/bio-what-s-roi-a-covid-19-vaccine-we-have-no-idea-says-pfizer